Dermavant supports investigator/externally led research programs related to Dermavant’s compounds and relevant therapeutic areas of interest.
The objectives of these programs are to:
These programs are open to healthcare providers, researchers and institutions interested in conducting external research within countries in which Dermavant has obtained regulatory approval.
Investigators and/or their affiliated institutions and networks assume responsibility for all aspects of the study, including design, regulatory submission, initiation, conduct, and monitoring of the research, along with data analysis and communication (e.g. abstract, manuscript, and final study report) of the results.
Proposals submitted to Dermavant are reviewed by Dermavant's scientific and medical committee. Approval of a proposal is based on alignment with Dermavant's IIS areas of interest, scientific merit, patient safety considerations, unmet medical need, study design, availability of resources, and feasibility of study conduct. Support for approved proposals may be provided in the form of study drug supply, funding, or both depending on the request, and is contingent upon a final approved protocol, regulatory clearance, Investigator Review Board approval, and full execution of a research agreement.
Current IIS areas of interest:
Please submit all IIS proposals and / or inquiries via email at firstname.lastname@example.org